275 related articles for article (PubMed ID: 30741560)
1. Neurofibromatosis Type 1: Description of a Novel Diagnostic Scoring System in Pediatric Optic Nerve Glioma.
Eid H; Crevier-Sorbo G; Aldraihem A; Menegotto F; Wilson N
AJR Am J Roentgenol; 2019 Apr; 212(4):892-898. PubMed ID: 30741560
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of optic nerve diameters in individuals with neurofibromatosis and comparison of normative values in different pediatric age groups.
Tosun M; Güngör M; Uslu H; Anık Y
Clin Imaging; 2022 May; 85():83-88. PubMed ID: 35259715
[TBL] [Abstract][Full Text] [Related]
3. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
Wolsey DH; Larson SA; Creel D; Hoffman R
J AAPOS; 2006 Aug; 10(4):307-11. PubMed ID: 16935228
[TBL] [Abstract][Full Text] [Related]
4. Quantitative MRI criteria for optic pathway enlargement in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Biggs E; Alsharid MA; Packer RJ; Linguraru MG
Neurology; 2016 Jun; 86(24):2264-70. PubMed ID: 27170570
[TBL] [Abstract][Full Text] [Related]
5. Optic nerve tortuosity in children with neurofibromatosis type 1.
Ji J; Shimony J; Gao F; McKinstry RC; Gutmann DH
Pediatr Radiol; 2013 Oct; 43(10):1336-43. PubMed ID: 23636538
[TBL] [Abstract][Full Text] [Related]
6. Anisometropia in children with neurofibromatosis type 1 and unilateral optic nerve glioma.
Dotan G; Keren S; Stolovitch C; Toledano-Alhadef H; Kesler A
J AAPOS; 2014 Jun; 18(3):255-7. PubMed ID: 24924279
[TBL] [Abstract][Full Text] [Related]
7. Risk of optic pathway glioma in children with neurofibromatosis type 1 and optic nerve tortuosity or nerve sheath thickening.
Levin MH; Armstrong GT; Broad JH; Zimmerman R; Bilaniuk LT; Feygin T; Li Y; Liu GT; Fisher MJ
Br J Ophthalmol; 2016 Apr; 100(4):510-4. PubMed ID: 26294105
[TBL] [Abstract][Full Text] [Related]
8. Optic pathway glioma volume predicts retinal axon degeneration in neurofibromatosis type 1.
Avery RA; Mansoor A; Idrees R; Trimboli-Heidler C; Ishikawa H; Packer RJ; Linguraru MG
Neurology; 2016 Dec; 87(23):2403-2407. PubMed ID: 27815398
[TBL] [Abstract][Full Text] [Related]
9. Comparison of multi-shot and single shot echo-planar diffusion tensor techniques for the optic pathway in patients with neurofibromatosis type 1.
Ho CY; Deardorff R; Kralik SF; West JD; Wu YC; Shih CS
Neuroradiology; 2019 Apr; 61(4):431-441. PubMed ID: 30684113
[TBL] [Abstract][Full Text] [Related]
10. Surveillance magnetic resonance imaging for isolated optic pathway gliomas: is gadolinium necessary?
Maloney E; Stanescu AL; Perez FA; Iyer RS; Otto RK; Leary S; Steuten L; Phipps AI; Shaw DWW
Pediatr Radiol; 2018 Sep; 48(10):1472-1484. PubMed ID: 29789890
[TBL] [Abstract][Full Text] [Related]
11. Defining optic nerve tortuosity.
Armstrong GT; Localio AR; Feygin T; Bilaniuk L; Phillips PC; Fisher MJ; Strom BL; Zimmerman R
AJNR Am J Neuroradiol; 2007 Apr; 28(4):666-71. PubMed ID: 17416818
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic performance of an unenhanced MRI exam for tumor follow-up of the optic pathway gliomas in children.
Marsault P; Ducassou S; Menut F; Bessou P; Havez-Enjolras M; Chateil JF
Neuroradiology; 2019 Jun; 61(6):711-720. PubMed ID: 30904949
[TBL] [Abstract][Full Text] [Related]
13. Neurofibromatosis type 1 and sporadic optic gliomas.
Singhal S; Birch JM; Kerr B; Lashford L; Evans DG
Arch Dis Child; 2002 Jul; 87(1):65-70. PubMed ID: 12089128
[TBL] [Abstract][Full Text] [Related]
14. The Utility of Early Brain MRI for Patients with Neurofibromatosis Type 1 and Optic Pathway Glioma: A Long-Term Follow-Up in a Tertiary Referral Hospital.
Rony C; Aharoni S; Halevy A
Neuropediatrics; 2022 Oct; 53(5):370-375. PubMed ID: 35381604
[TBL] [Abstract][Full Text] [Related]
15. Growth hormone excess in children with neurofibromatosis type-1 and optic glioma.
Cambiaso P; Galassi S; Palmiero M; Mastronuzzi A; Del Bufalo F; Capolino R; Cacchione A; Buonuomo PS; Gonfiantini MV; Bartuli A; Cappa M; Macchiaiolo M
Am J Med Genet A; 2017 Sep; 173(9):2353-2358. PubMed ID: 28631895
[TBL] [Abstract][Full Text] [Related]
16. Assessment of the visual pathways in patients with neurofibromatosis-1 by 3S-space technique with 3-Tesla MRI.
Saraç Ö; Alğin O; Beyazal M; Anlar FB; Varan A; Kansu AT
Turk J Med Sci; 2019 Dec; 49(6):1626-1633. PubMed ID: 31655505
[TBL] [Abstract][Full Text] [Related]
17. Quantitative MRI demonstrates abnormalities of the third ventricle subventricular zone in neurofibromatosis type-1 and sporadic paediatric optic pathway glioma.
Boonzaier NR; Hales PW; D'Arco F; Walters BC; Kaur R; Mankad K; Cooper J; Liasis A; Smith V; O'Hare P; Hargrave D; Clark CA
Neuroimage Clin; 2020; 28():102447. PubMed ID: 33038669
[TBL] [Abstract][Full Text] [Related]
18. Optic Gliomas in Neurofibromatosis Type 1.
Parkhurst E; Abboy S
J Pediatr Ophthalmol Strabismus; 2016 Nov; 53(6):334-338. PubMed ID: 27537249
[TBL] [Abstract][Full Text] [Related]
19. Isolated optic nerve gliomas: a multicenter historical cohort study.
Shofty B; Ben-Sira L; Kesler A; Jallo G; Groves ML; Iyer RR; Lassaletta A; Tabori U; Bouffet E; Thomale UW; Hernáiz Driever P; Constantini S;
J Neurosurg Pediatr; 2017 Dec; 20(6):549-555. PubMed ID: 28984541
[TBL] [Abstract][Full Text] [Related]
20. Natural history of optic pathway gliomas in a cohort of unselected patients affected by Neurofibromatosis 1.
Trevisson E; Cassina M; Opocher E; Vicenzi V; Lucchetta M; Parrozzani R; Miglionico G; Mardari R; Viscardi E; Midena E; Clementi M
J Neurooncol; 2017 Sep; 134(2):279-287. PubMed ID: 28577031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
